{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:50:32Z","timestamp":1790769032210,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T00:00:00Z","timestamp":1567987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T00:00:00Z","timestamp":1567987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008397","name":"Velux Fonden","doi-asserted-by":"publisher","award":["-"],"award-info":[{"award-number":["-"]}],"id":[{"id":"10.13039\/100008397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00702-019-02073-1","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T05:02:15Z","timestamp":1568005335000},"page":"1493-1500","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["FGF2 and dual agonist of NCAM and FGF receptor 1, Enreptin, rescue neurite outgrowth loss in hippocampal neurons expressing mutated huntingtin proteins"],"prefix":"10.1007","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7992-8885","authenticated-orcid":false,"given":"Mirolyuba","family":"Ilieva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troels T.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislava","family":"Pankratova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,9]]},"reference":[{"key":"2073_CR53","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/ng0893-398","volume":"4","author":"SE Andrew","year":"2008","unstructured":"Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilmann J, Adam S et al (1993) The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat Genet 4:398\u2013403","journal-title":"Nat Genet"},{"issue":"1","key":"2073_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neurobiolaging.2012.07.018","volume":"34","author":"RT Bartus","year":"2013","unstructured":"Bartus RT, Baumann TL, Brown L, Kruegel BR, Ostrove JM, Herzog CD (2013) Advancing neurotrophic factors as treatments for age-related neurodegenerative diseases: developing and demonstrating \u201cclinical proof-of-concept\u201d for AAV-neurturin (CERE-120) in Parkinson\u2019s disease. Neurobiol Aging 34(1):35\u201361","journal-title":"Neurobiol Aging"},{"issue":"9","key":"2073_CR2","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1136\/jnnp-2015-312413","volume":"87","author":"F Begeti","year":"2016","unstructured":"Begeti F, Schwab LC, Mason SL, Barker RA (2016) Hippocampal dysfunction defines disease onset in Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 87(9):975\u2013981","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"2073_CR3","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/j.1365-2826.2009.01898.x","volume":"21","author":"TW Boesgaard","year":"2009","unstructured":"Boesgaard TW, Nielsen TT, Josefsen K, Hansen T, J\u00f8rgensen T, Pedersen O, N\u00f8rrem\u00f8lle A, Nielsen JE, Hasholt L (2009) Huntington\u2019s disease does not appear to increase the risk of diabetes mellitus. J Neuroendocrinol 21(9):770\u2013776","journal-title":"J Neuroendocrinol"},{"issue":"1","key":"2073_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.brainresrev.2008.04.001","volume":"58","author":"I Bohanna","year":"2008","unstructured":"Bohanna I, Georgiou-Karistianis N, Hannan AJ, Egan GF (2008) Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington\u2019s disease. Brain Res Rev 58(1):209\u2013225","journal-title":"Brain Res Rev"},{"issue":"10","key":"2073_CR5","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.1172\/JCI74809","volume":"124","author":"V Brito","year":"2014","unstructured":"Brito V, Giralt A, Enriquez-Barreto L, Puigdell\u00edvol M, Suelves N, Zamora-Moratalla A et al (2014) Neurotrophin receptor p75(NTR) mediates Huntington\u2019s disease-associated synaptic and memory dysfunction. J Clin Invest 124(10):4411\u20134428","journal-title":"J Clin Invest"},{"issue":"4","key":"2073_CR6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.stemcr.2014.07.011","volume":"3","author":"RL Carter","year":"2014","unstructured":"Carter RL, Chen Y, Kunkanjanawan T, Xu Y, Moran SP, Putkhao K et al (2014) Reversal of cellular phenotypes in neural cells derived from Huntington\u2019s disease monkey-induced pluripotent stem cells. Stem Cell Rep 3(4):585\u2013593","journal-title":"Stem Cell Rep"},{"issue":"3","key":"2073_CR7","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0166-2236(00)01721-5","volume":"24","author":"E Cattaneo","year":"2001","unstructured":"Cattaneo E, Rigamonti D, Goffredo D, Zuccato C, Squitieri F, Sipione S (2001) Loss of normal huntingtin function: new developments in Huntington\u2019s disease research. Trends Neurosci 24(3):182\u2013188","journal-title":"Trends Neurosci"},{"issue":"2","key":"2073_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3233\/JHD-170247","volume":"6","author":"SS Chaganti","year":"2017","unstructured":"Chaganti SS, McCusker EA, Loy CT (2017) What do we know about late onset Huntington\u2019s disease? J Huntingtons Dis 6(2):95\u2013103","journal-title":"J Huntingtons Dis"},{"issue":"7","key":"2073_CR9","doi-asserted-by":"publisher","first-page":"E1618","DOI":"10.1073\/pnas.1716871115","volume":"115","author":"Z Dargaei","year":"2018","unstructured":"Dargaei Z, Bang JY, Mahadevan V, Khademullah CS, Bedard S et al (2018) Restoring GABAergic inhibition rescues memory deficits in a Huntington\u2019s disease mouse model. PNAS 115(7):E1618\u2013E1626","journal-title":"PNAS"},{"key":"2073_CR10","doi-asserted-by":"publisher","first-page":"865","DOI":"10.4161\/cc.7.7.5615","volume":"7","author":"EL Davenport","year":"2008","unstructured":"Davenport EL, Morgan GJ, Davies FE (2008) Untangling the unfolded protein response. Cell Cycle 7:865\u2013869","journal-title":"Cell Cycle"},{"issue":"5334","key":"2073_CR11","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N (1997) Aggregation of Huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277(5334):1990\u20131993","journal-title":"Science"},{"issue":"3","key":"2073_CR12","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.nbd.2012.07.016","volume":"48","author":"MN Enevoldsen","year":"2012","unstructured":"Enevoldsen MN, Kochoyan A, Jurgenson M, Jaako K, Dmytriyeva O, Walmod PS et al (2012) Neuroprotective and memory enhancing properties of a dual agonist of the FGF receptor and NCAM. Neurobiol Dis 48(3):533\u2013545","journal-title":"Neurobiol Dis"},{"key":"2073_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/76095","volume":"25","author":"A Follenzi","year":"2000","unstructured":"Follenzi A, Ailles LE, Bakovic S, Geuna M, Naldini L (2000) Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet 25:217\u2013222","journal-title":"Nat Genet"},{"issue":"1","key":"2073_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.brainresrev.2007.05.014","volume":"56","author":"E Gascon","year":"2007","unstructured":"Gascon E, Vutskits L, Kiss JZ (2007) Polysialic acid-neural cell adhesion molecule in brain plasticity: from synapses to integration of new neurons. Brain Res Rev 56(1):101\u2013118","journal-title":"Brain Res Rev"},{"issue":"3","key":"2073_CR15","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.nbd.2005.05.006","volume":"20","author":"JM Gil","year":"2005","unstructured":"Gil JM, Mohapel P, Ara\u00fajo IM, Popovic N, Li JY, Brundin P, Peters\u00e9n A (2005) Reduced hippocampal neurogenesis in R6\/2 transgenic Huntington\u2019s disease mice. Neurobiol Dis 20(3):744\u2013751","journal-title":"Neurobiol Dis"},{"issue":"8","key":"2073_CR16","doi-asserted-by":"publisher","first-page":"15592","DOI":"10.1038\/ncomms15592","volume":"30","author":"A Giralt","year":"2017","unstructured":"Giralt A, Brito V, Chevy Q, Simonnet C, Otsu Y, Cifuentes-D\u00edaz C et al (2017) Pyk2 modulates hippocampal excitatory synapses and contributes to cognitive deficits in a Huntington\u2019s disease model. Nat Commun 30(8):15592","journal-title":"Nat Commun"},{"issue":"3","key":"2073_CR17","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.neuron.2010.06.027","volume":"67","author":"JD Godin","year":"2010","unstructured":"Godin JD, Colombo K, Molina-Calavita M, Keryer G, Zala D, Charrin BC et al (2010) Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis. Neuron 67(3):392\u2013406","journal-title":"Neuron"},{"key":"2073_CR18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0968-0004(03)00168-3","volume":"28","author":"P Harjes","year":"2003","unstructured":"Harjes P, Wanker EE (2003) The hunt for huntingtin function: interaction partners tell many different stories. Trends Biochem Sci 28:425\u2013433","journal-title":"Trends Biochem Sci"},{"issue":"7","key":"2073_CR19","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1136\/jmg.38.7.450","volume":"38","author":"LW Ho","year":"2001","unstructured":"Ho LW, Brown R, Maxwell M, Wyttenbach A, Rubinsztein DC (2001) Wild type Huntingtin reduces the cellular toxicity of mutant Huntingtin in mammalian cell models of Huntington\u2019s disease. J Med Genet 38(7):450\u2013452","journal-title":"J Med Genet"},{"issue":"50","key":"2073_CR20","doi-asserted-by":"publisher","first-page":"18189","DOI":"10.1073\/pnas.0506375102","volume":"102","author":"K Jin","year":"2005","unstructured":"Jin K, LaFevre-Bernt M, Sun Y, Chen S, Gafni J, Crippen D et al (2005) FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington\u2019s disease. PNAS 102(50):18189\u201318194","journal-title":"PNAS"},{"issue":"4","key":"2073_CR21","doi-asserted-by":"publisher","first-page":"e94562","DOI":"10.1371\/journal.pone.0094562","volume":"9","author":"K Kolodziejczyk","year":"2014","unstructured":"Kolodziejczyk K, Parsons MP, Southwell AL, Hayden MR, Raymond LA (2014) Striatal synaptic dysfunction and hippocampal plasticity deficits in the Hu97\/18 mouse model of Huntington disease. PLoS One 9(4):e94562","journal-title":"PLoS One"},{"issue":"4","key":"2073_CR22","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/j.1471-4159.2005.03605.x","volume":"96","author":"BR Leavitt","year":"2006","unstructured":"Leavitt BR, van Raamsdonk JM, Shehadeh J, Fernandes H, Murphy Z, Graham RK et al (2006) Wild-type huntingtin protects neurons from excitotoxicity. J Neurochem 96(4):1121\u20131129","journal-title":"J Neurochem"},{"key":"2073_CR23","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1038\/ncomms3753","volume":"4","author":"J Leitman","year":"2013","unstructured":"Leitman J, Ulrich Hartl F, Lederkremer GZ (2013) Soluble forms of polyQ-expanded huntingtin rather than large aggregates cause endoplasmic reticulum stress. Nat Commun 4:2753","journal-title":"Nat Commun"},{"issue":"2","key":"2073_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2165\/00063030-200519020-00003","volume":"19","author":"YS Levy","year":"2005","unstructured":"Levy YS, Gilgun-Sherki Y, Melamed E, Offen D (2005) Therapeutic potential of neurotrophic factors in neurodegenerative diseases. BioDrugs 19(2):97\u2013127","journal-title":"BioDrugs"},{"issue":"21","key":"2073_CR25","doi-asserted-by":"publisher","first-page":"8473","DOI":"10.1523\/JNEUROSCI.21-21-08473.2001","volume":"21","author":"H Li","year":"2001","unstructured":"Li H, Li SH, Yu ZX, Shelbourne P, Li XJ (2001) Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington\u2019s disease mice. J Neurosc 21(21):8473\u20138481","journal-title":"J Neurosc"},{"issue":"10","key":"2073_CR26","doi-asserted-by":"publisher","first-page":"e109621","DOI":"10.1371\/journal.pone.0109621","volume":"9","author":"Y Liu","year":"2014","unstructured":"Liu Y, Xue Y, Ridley S, Zhang D, Rezvani K, Fu XD, Wang H (2014) Direct reprogramming of Huntington\u2019s disease patient fibroblasts into neuron-like cells leads to abnormal neurite outgrowth, increased cell death, and aggregate formation. PLoS One 9(10):e109621","journal-title":"PLoS One"},{"key":"2073_CR27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/(SICI)1097-4547(19970115)47:2<163::AID-JNR5>3.0.CO;2-D","volume":"47","author":"TE Maar","year":"1997","unstructured":"Maar TE, R\u00f8nn LC, Bock E, Berezin V, Moran J, Pasantes-Morales H, Schousboe A (1997) Characterization of microwell cultures of dissociated brain tissue for studies of cell-cell interactions. J Neurosci Res 47:163\u2013172","journal-title":"J Neurosci Res"},{"key":"2073_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/00005072-199902000-00003","volume":"58","author":"ML Maat-Schieman","year":"1999","unstructured":"Maat-Schieman ML, Dorsman JC, Smoor MA, Siesling S, Van Duinen SG, Verschuuren JJ et al (1999) Distribution of inclusions in neuronal nuclei and dystrophic neurites in Huntington disease brain. J Neuropathol Exp Neurol 58:129\u2013137","journal-title":"J Neuropathol Exp Neurol"},{"key":"2073_CR29","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L et al (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72:971\u2013983","journal-title":"Cell"},{"issue":"3","key":"2073_CR30","first-page":"237","volume":"58","author":"ID Maksimovi\u0107","year":"2001","unstructured":"Maksimovi\u0107 ID, Jovanovi\u0107 MD, Coli\u0107 M, Mihajlovi\u0107 R, Mi\u0107i\u0107 D, Selakovi\u0107 V et al (2001) Oxidative damage and metabolic dysfunction in experimental Huntington\u2019s disease: selective vulnerability of the striatum and hippocampus. Vojnosanit Pregl 58(3):237\u2013242","journal-title":"Vojnosanit Pregl"},{"key":"2073_CR31","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nrn2189","volume":"8","author":"I Mason","year":"2007","unstructured":"Mason I (2007) Initiation to end point: the multiple roles offibroblast growth factors in neural development. Nat Rev Neurosci 8:583\u2013596","journal-title":"Nat Rev Neurosci"},{"issue":"13","key":"2073_CR32","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1523\/JNEUROSCI.20-13-05115.2000","volume":"20","author":"KP Murphy","year":"2000","unstructured":"Murphy KP, Carter RJ, Lione LA, Mangiarini L, Mahal A, Bates GP et al (2000) Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington\u2019s disease mutation. J Neurosci 20(13):5115\u20135123","journal-title":"J Neurosci"},{"issue":"2","key":"2073_CR33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1602\/neurorx.1.2.255","volume":"1","author":"RH Myers","year":"2004","unstructured":"Myers RH (2004) Huntington\u2019s disease genetics. NeuroRx 1(2):255\u2013262","journal-title":"NeuroRx"},{"issue":"4","key":"2073_CR34","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/j.1471-4159.2004.02779.x","volume":"91","author":"JL Neiiendam","year":"2004","unstructured":"Neiiendam JL, K\u00f8hler LB, Christensen C, Li S, Pedersen MV, Ditlevsen DK et al (2004) An NCAM-derived FGF-receptor agonist, the FGL-peptide, induces neurite outgrowth and neuronal survival in primary rat neurons. J Neurochem 91(4):920\u2013935","journal-title":"J Neurochem"},{"issue":"3","key":"2073_CR35","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/wdev.176","volume":"4","author":"DM Ornitz","year":"2015","unstructured":"Ornitz DM, Itoh N (2015) The Fibroblast Growth Factor signaling pathway. Wiley Interdiscip Rev Dev Biol 4(3):215\u2013266","journal-title":"Wiley Interdiscip Rev Dev Biol"},{"key":"2073_CR36","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1093\/brain\/awq101","volume":"133","author":"S Pankratova","year":"2010","unstructured":"Pankratova S, Kiryushko D, Sonn K, Soroka V, K\u00f8hler LB, Rathje M et al (2010) Neuroprotective properties of a novel, non-haematopoietic agonist of the erythropoietin receptor. Brain 133:2281\u20132294","journal-title":"Brain"},{"issue":"5","key":"2073_CR37","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s11910-011-0215-x","volume":"11","author":"JS Paulsen","year":"2011","unstructured":"Paulsen JS (2011) Cognitive impairment in Huntington disease: diagnosis and treatment. Curr Neurol Neurosci Rep 11(5):474\u2013483","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"5","key":"2073_CR38","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/cne.21272","volume":"501","author":"E Petrasch-Parwez","year":"2007","unstructured":"Petrasch-Parwez E, Nguyen HP, L\u00f6bbecke-Schumacher M, Habbes HW, Wieczorek S, Riess O et al (2007) Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease. J Comp Neurol 501(5):716\u2013730","journal-title":"J Comp Neurol"},{"key":"2073_CR39","volume-title":"Juvenile Huntington\u2019s Disease and Other Trinucleotide Repeat Disorders","author":"OWJ Quarrell","year":"2009","unstructured":"Quarrell OWJ, Nance MA (2009) The diagnostic challenge. In: Quarrell OWJ, Brewer HM, Squitieri F, Barker RA, Nance MA, Landwehrmeyer BG (eds) Juvenile Huntington\u2019s Disease and Other Trinucleotide Repeat Disorders. Oxford University Press, New York"},{"key":"2073_CR40","doi-asserted-by":"publisher","first-page":"e4f8606b742ef3","DOI":"10.1371\/4f8606b742ef3","volume":"4","author":"O Quarrell","year":"2012","unstructured":"Quarrell O, O\u2019Donovan KL, Bandmann O, Strong M (2012) The prevalence of juvenile Huntington\u2019s disease: a review of the literature and meta-analysis. PLoS Curr 4:e4f8606b742ef3","journal-title":"PLoS Curr"},{"key":"2073_CR41","doi-asserted-by":"publisher","first-page":"14545","DOI":"10.1074\/jbc.C100044200","volume":"276","author":"D Rigamonti","year":"2001","unstructured":"Rigamonti D, Sipione S, Goffredo D, Zuccato C, Fossale E, Cattaneo E (2001) Huntingtin\u2019s neuroprotective activity occurs via inhibition of procaspase-9 processing. J Biol Chem 276:14545\u201314548","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"2073_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0165-0270(00)00228-4","volume":"100","author":"LC R\u00f8nn","year":"2000","unstructured":"R\u00f8nn LC, Ralets I, Hartz BP, Bech M, Berezin A, Berezin V et al (2000) A simple procedure for quantification of neurite outgrowth based on stereological principles. J Neurosci Methods 100(1\u20132):25\u201332","journal-title":"J Neurosci Methods"},{"key":"2073_CR43","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RAC Roos","year":"2010","unstructured":"Roos RAC (2010) Huntington\u2019s disease: a clinical review. Orphanet J Rare Dis 5:40","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"2073_CR44","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0896-6273(02)00872-3","volume":"35","author":"CA Ross","year":"2002","unstructured":"Ross CA (2002) Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington\u2019s disease and related disorders. Neuron 35(5):819\u2013822","journal-title":"Neuron"},{"issue":"5","key":"2073_CR45","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","volume":"89","author":"F Saudou","year":"2016","unstructured":"Saudou F, Humbert S (2016) The biology of huntingtin. Neuron 89(5):910\u2013926","journal-title":"Neuron"},{"issue":"1","key":"2073_CR46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.neuron.2012.05.024","volume":"75","author":"DI Shirasaki","year":"2012","unstructured":"Shirasaki DI, Greiner ER, Al-Ramahi I, Gray M, Boontheung P, Geschwind DH et al (2012) Network organization of the huntingtin proteomic interactome in mammalian brain. Neuron 75(1):41\u201357","journal-title":"Neuron"},{"issue":"5","key":"2073_CR47","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/jnr.22281","volume":"88","author":"K Sonn","year":"2010","unstructured":"Sonn K, Pankratova S, Korshunova I, Zharkovsky A, Bock E, Berezin V, Kiryushko D (2010) A metallothionein mimetic peptide protects neurons against kainic acid-induced excitotoxicity. J Neurosci Res 88(5):1074\u20131082","journal-title":"J Neurosci Res"},{"issue":"5","key":"2073_CR48","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1136\/jnnp.56.5.487","volume":"56","author":"E Spargo","year":"1993","unstructured":"Spargo E, Everall IP, Lantos PL (1993) Neuronal loss in the hippocampus in Huntington\u2019s disease: a comparison with HIV infection. J Neurol Neurosurg Psychiatry 56(5):487\u2013491","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"2073_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","volume":"10","author":"SJ Tabrizi","year":"2011","unstructured":"Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R et al (2011) Biological and clinical changes in premanifest and early stage Huntington\u2019s disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol 10(1):31\u201342","journal-title":"Lancet Neurol"},{"issue":"5","key":"2073_CR50","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/hmg\/8.5.839","volume":"8","author":"MT Usdin","year":"1999","unstructured":"Usdin MT, Shelbourne PF, Myers RM, Madison DV (1999) Impaired synaptic plasticity in mice carrying the Huntington\u2019s disease mutation. Hum Mol Genet 8(5):839\u2013846","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2073_CR51","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.expneurol.2006.10.014","volume":"204","author":"K van der Borght","year":"2007","unstructured":"van der Borght K, Brundin P (2007) Reduced expression of PSA-NCAM in the hippocampus and piriform cortex of the R6\/1 and R6\/2 mouse models of Huntington\u2019s disease. Exp Neurol 204(1):473\u2013478","journal-title":"Exp Neurol"},{"issue":"7","key":"2073_CR52","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jpsychires.2007.05.008","volume":"42","author":"E Vassos","year":"2008","unstructured":"Vassos E, Panas M, Kladi A, Vassilopoulos D (2008) Effect of CAG repeat length on psychiatric disorders in Huntington\u2019s disease. J Psychiatr Res 42(7):544\u2013549","journal-title":"J Psychiatr Res"},{"key":"2073_CR54","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO (2007) Huntington\u2019s disease. Lancet 369:218\u2013228","journal-title":"Lancet"},{"key":"2073_CR55","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/ng1297-404","volume":"17","author":"JK White","year":"1997","unstructured":"White JK, Auerbach W, Duyao MP, Vonsattel JP, Gusella JF, Joyner AL et al (1997) Huntingtin is required for neurogenesis and is not impaired by the Huntington\u2019s disease CAG expansion. Nat Genet 17:404\u2013410","journal-title":"Nat Genet"},{"key":"2073_CR56","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.brainres.2015.09.020","volume":"1638","author":"N Zhang","year":"2016","unstructured":"Zhang N, Bailus BJ, Ring KL, Ellerby LM (2016) iPSC-based drug screening for Huntington\u2019s disease. Brain Res 1638:42\u201356","journal-title":"Brain Res"},{"issue":"1","key":"2073_CR57","doi-asserted-by":"publisher","first-page":"4272","DOI":"10.1038\/s41467-018-06675-3","volume":"9","author":"H Zhang","year":"2018","unstructured":"Zhang H, Zhang C, Vincent J, Zala D, Benstaali C, Sainlos M et al (2018) Modulation of AMPA receptor surface diffusion restores hippocampal plasticity and memory in Huntington\u2019s disease models. Nat Commun 9(1):4272","journal-title":"Nat Commun"},{"issue":"12","key":"2073_CR58","doi-asserted-by":"publisher","first-page":"9873","DOI":"10.1128\/JVI.72.12.9873-9880.1998","volume":"72","author":"R Zufferey","year":"1998","unstructured":"Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L et al (1998) Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72(12):9873\u20139880","journal-title":"J Virol"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-019-02073-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-019-02073-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-019-02073-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T03:15:27Z","timestamp":1721704527000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-019-02073-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,9]]},"references-count":58,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["2073"],"URL":"https:\/\/doi.org\/10.1007\/s00702-019-02073-1","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,9]]},"assertion":[{"value":"28 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors state that there is no conflict of interest relevant to this article, nor has it previously been published.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Animals were treated in accordance with the Danish Animal Welfare Act, and the study was approved by the Department of Experimental Medicine at the University of Copenhagen.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Bioethics"}}]}}